The interaction between DC-SIGN and tumor-associated Le glycans results in enhanced IL-10 production, and impairs production of pro-inflammatory cytokines in tumor-associated macrophages (TAMs) from breast adenocarcinoma and melanoma patients, which leads to decrease capacity to elicit anti-tumor T-cell responses (73). The gene discussed is CD209; the disease is melanoma.